Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007US20070264229 Peptides for Treatment of Autoimmune Disease
11/15/2007US20070264228 Methods for treating viral infection using il-28 and il-29
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264195 Modulation of Activity of Neurotrophins
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007US20070264191 Materials and Methods Relating to the Treatment of Glioblastomas
11/15/2007DE19544507B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
11/15/2007CA2653748A1 Non-natural amino acid substituted polypeptides
11/15/2007CA2652247A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
11/15/2007CA2651691A1 Glutaminase and 6-diazo-5-oxo-l-norleucine (don) for cancer therapy
11/15/2007CA2651348A1 Rage fusion proteins, formulations, and methods of use thereof
11/15/2007CA2651263A1 Urodilatin cancer treatment
11/15/2007CA2651201A1 Use of a compound with rankl activity
11/15/2007CA2651194A1 Methods for treating neovascular diseases
11/15/2007CA2651125A1 Phage derived antimicrobial activities
11/15/2007CA2650963A1 St2 as a cardiovascular disease marker for high-bmi or impaired renal function patients
11/15/2007CA2650877A1 Vitreous administration of erythropoietin
11/15/2007CA2650718A1 Methods for the treatment of muscular dystrophy associated with dysferlin-deficiency
11/15/2007CA2650495A1 Use of alpha-lactalbumin for regulation of glycemia
11/15/2007CA2649627A1 Methods and compositions for remediation of disc herniation by modifying structure
11/15/2007CA2649235A1 Insulin derivative
11/15/2007CA2649063A1 Use of thymosin .alpha.1,alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
11/15/2007CA2648487A1 Polypeptide antagonist
11/15/2007CA2648165A1 Biomarkers for endometrial proliferation
11/15/2007CA2621264A1 Parathyroid hormone analogues and methods of use
11/14/2007EP1854892A1 Modified viral surface proteins wich bind to cells of tumor vasculature
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854876A2 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
11/14/2007EP1854809A1 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/14/2007EP1854808A2 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/14/2007EP1854481A2 Cerebral stroke/cerebral edema preventive or remedy containing IL-8 binding inhibitor as active ingredient
11/14/2007EP1854480A2 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/14/2007EP1854477A2 Compositions and methods for treating ophthalmic disorders
11/14/2007EP1854476A2 Use of relaxin to treat diseases related to vasoconstriction
11/14/2007EP1854475A1 Use of leptin for the prevention of excess body weight and composition containing leptin
11/14/2007EP1854474A1 Immunopotentiating agent
11/14/2007EP1854473A1 Preventive/therapeutic agent for cancer
11/14/2007EP1854472A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
11/14/2007EP1854471A1 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/14/2007EP1854458A1 Use of a compound with RANKL activity
11/14/2007EP1853631A2 Fc-fusion constructs binding to phosphatidylserine and their therapeutic use
11/14/2007EP1853626A2 Amyloid-binding peptides, analogues and uses thereof
11/14/2007EP1853623A1 Animal product free system and process for purifying a botulinum toxin
11/14/2007EP1853622A1 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/14/2007EP1853603A1 Peptidomimetic compounds and preparation of biologically active derivatives
11/14/2007EP1853324A1 Caspase-3 substrate comprising imaging agents
11/14/2007EP1853323A2 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3)
11/14/2007EP1853317A2 Compositions and methods for treating or preventing flaviviridae infections
11/14/2007EP1853315A1 Treatment for mucositis
11/14/2007EP1853312A2 Methods and compositions for modulating tweak and fn14 activity
11/14/2007EP1853305A2 Survivin peptide vaccine
11/14/2007EP1853304A2 Modulation of muc1 activity
11/14/2007EP1853303A1 Stabilized compositions for topical administration and methods of making same
11/14/2007EP1853302A2 Antiangiogenic agents with aldesleukin
11/14/2007EP1853301A2 Method and composition for repairing heart tissue
11/14/2007EP1853300A2 Methods of using death receptor agonists and egfr inhibitors
11/14/2007EP1853299A2 Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders
11/14/2007EP1853298A2 Therapeutic combination of a vegf antagonist (vegf trap) and an anti-hypertensive agent
11/14/2007EP1853297A1 Insulin-like growth factor binding protein-4 compounds and methods for inhibiting angiogenesis and tumor growth in mammalian cells
11/14/2007EP1853296A1 Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events
11/14/2007EP1853295A2 Methods and compositions for the treatment of gastrointestinal disorders
11/14/2007EP1853294A2 Anti-angiogenic compounds
11/14/2007EP1853293A1 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease
11/14/2007EP1853292A1 Pharmaceutical composition for the prevention and treatment of cancer
11/14/2007EP1853291A1 Bacteriophage and prophage proteins in cancer gene therapy
11/14/2007EP1853290A1 Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
11/14/2007EP1853289A2 Novel polypeptide ligands for toll-like receptor 2 (tlr2)
11/14/2007EP1853288A2 Intranasal administration of active agents to the central nervous system
11/14/2007EP1853287A2 Synthetic peptide copolymers for treatment and prevention of cardiovascular disorders
11/14/2007EP1853283A1 Activating extraction of demineralized bone matrix
11/14/2007EP1853250A1 Combinations and modes of administration of therapeutic agents and combination therapy
11/14/2007EP1853231A2 Apparatus and method for transdermal delivery of erythropoetin-based agents
11/14/2007EP1853113A2 Revascularization of ischemic retinal tissue and screening method therefor
11/14/2007EP1700120A4 Marker for neuromyelitis optica
11/14/2007EP1696909B1 Benzothiazole derivatives for the treatment of diabetes
11/14/2007EP1654261B1 Hepatitis c inhibitor compounds
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007EP1576153B1 Device and process for the preparation of autologous thrombin serum
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1361895B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1343903B1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
11/14/2007EP1339433B1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
11/14/2007EP1296740B1 Delivery of a substance into the dermis
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP1091735B1 Improved enriched platelet wound healant
11/14/2007EP1053011B1 Mixed micellar pharmaceutical delivery system and method of preparation
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0960937B1 Novel semaphorin gene: semaphorin y
1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 3163